Metagenomic Sequencing Market to Reach USD 9.25 Billion by 2033 at 16.7% CAGR; North America Leads with 40% Share - Key Players: Illumina Inc., Thermo Fisher Scientific, QIAGEN N.V.

The global metagenomic sequencing market reached USD 2.70 billion in 2025 and is expected to reach USD 9.25 billion by 2033, growing at a CAGR of 16.7% from 2026 to 2033. The market is witnessing strong growth driven by the increasing adoption of advanced genomic technologies and the rising demand for comprehensive microbial analysis.

Market growth is fueled by the growing prevalence of infectious diseases, increasing applications in environmental and clinical research, and the rising need for rapid and accurate pathogen identification. Additionally, advancements in next-generation sequencing (NGS) technologies and bioinformatics tools are enhancing data analysis capabilities, further supporting market expansion.

Metagenomic sequencing is important for studying genetic material directly from environmental samples, allowing scientists to examine different microbial communities without having to grow them in a lab. It is widely used in applications such as microbiome research, disease diagnostics, and drug discovery. Continuous innovation in sequencing technologies, increasing research funding, and the growing focus on precision medicine are positioning the metagenomic sequencing market as a key segment within the global genomics and life sciences industry.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/metagenomic-sequencing-market?sai-v

Key Developments

✅ February 2026: The metagenomic sequencing market grew quickly in North America, Europe, and Asia Pacific due to a rising need for fast pathogen detection, microbiome analysis, and precision medicine.

✅ January 2026: Improvements in next-generation sequencing (NGS), portable sequencing devices, and AI-based bioinformatics tools made data more accurate, lowered costs, and allowed for immediate analysis

✅ December 2025: Leading companies such as Illumina Inc., Thermo Fisher Scientific, QIAGEN N.V., BGI Group, and Eurofins Scientific expanded sequencing platforms, reagents, and bioinformatics capabilities to strengthen global market presence.

✅ November 2025: More hospitals and labs started using metagenomic sequencing to help diagnose infections and track antibiotic resistance, which increased the need for high-throughput sequencing solutions.

✅ October 2025: Growing investments in microbiome research and personalized medicine accelerated development of advanced sequencing workflows for understanding host-microbe interactions and disease mechanisms.

✅ September 2025: In the United States and Europe, strong research funding, advanced healthcare infrastructure, and presence of leading genomics companies significantly supported market growth.

✅ August 2025: In China, India, and Japan, increasing investments in genomics, expanding biotechnology sectors, and rising awareness of microbiome applications accelerated regional expansion.

✅ July 2025: Expanding applications in environmental monitoring, agriculture, wastewater surveillance, and drug discovery, along with integration of cloud computing and multi-omics approaches, supported long-term global growth of the metagenomic sequencing market.

Ready to scale in the metagenomic sequencing market? Connect with the right partners and unlock new growth opportunities today: - https://www.datamintelligence.com/partner-identification-enquiry/metagenomic-sequencing-market?sai-v

Key Players
Thermo Fisher Scientific Inc. | Qiagen N.V. | BGI Group | Merck KGaA | Eurofins Scientific | Illumina, Inc. | Oxford Nanopore Technologies Ltd. | F. Hoffmann-La Roche Ltd. | Zymo Research Corporation | PacBio | Others

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=metagenomic-sequencing-market?sai-v

Market Drivers

A growing interest in microbiome research is a key factor driving the market, as metagenomic sequencing allows for detailed study of microbial communities in healthcare, environmental, and industrial areas.

Increasing prevalence of infectious diseases and antimicrobial resistance is boosting demand for advanced sequencing technologies capable of identifying novel pathogens and microbial diversity.

Growing adoption of next-generation sequencing (NGS) technologies is enhancing accuracy, speed, and cost-efficiency, supporting widespread market adoption.

Rising demand for early disease detection and personalized medicine is accelerating the use of metagenomics in clinical diagnostics and precision healthcare.

Expansion of applications in environmental monitoring, agriculture, and food safety is broadening the market scope beyond healthcare.

Increasing government funding and large-scale genomics projects are supporting research and innovation in metagenomic sequencing technologies.

Advancements in bioinformatics, AI, and data analytics are enabling efficient processing of complex genomic datasets.

Growing investments by pharmaceutical and biotechnology companies in drug discovery and microbiome-based therapeutics are further driving demand.

Industry Developments

Launch of advanced metagenomic sequencing platforms integrated with bioinformatics tools for faster and more accurate microbial analysis.

Strategic collaborations and innovations by key players such as Thermo Fisher Scientific, QIAGEN, Illumina, Merck KGaA, and F. Hoffmann-La Roche.

More people are using shotgun metagenomic sequencing because it can look at whole microbial genomes and find rare organisms.

Rising development of integrated sequencing and analytics solutions for clinical diagnostics and research applications.

There are a growing number of mergers, acquisitions, and partnerships aimed at expanding genomic databases and sequencing capabilities.

Expansion of metagenomics applications in drug discovery, industrial biotechnology, and environmental sustainability.

Increasing commercialization of sequencing services and cloud-based genomic analysis platforms.

Regional Insights

North America 40% share: "Leads the market due to strong research infrastructure, high funding for genomics, and early adoption of advanced sequencing technologies."

Europe 25% share: "Growth driven by increasing investments in life sciences research and expanding applications in healthcare and environmental monitoring."

Asia Pacific fastest-growing: "Supported by rising healthcare investments, expanding biotech sector, and increasing research activities in countries such as China, India, and Japan."

Latin America 5% share: "Emerging growth driven by improving research infrastructure and increasing adoption of genomic technologies."

Middle East & Africa 5% share: "Gradual growth supported by rising investments in healthcare research and genomics initiatives."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/metagenomic-sequencing-market?sai-v

Key Segments

➥ By Product & Service

Consumables: Represent the dominant segment, driven by continuous demand for reagents, kits, and library preparation materials required for sequencing workflows.

Instruments: Represent a significant segment, supported by advancements in high-throughput sequencing platforms and automation technologies.

Services: Represent a rapidly growing segment, fueled by increasing outsourcing of sequencing projects, bioinformatics analysis, and data interpretation services.

➥ By Technology

Shotgun Metagenomic Sequencing: Represent the dominant segment, driven by its comprehensive ability to analyze entire genetic material from environmental samples without prior knowledge.

16S rRNA Sequencing: Represent a significant segment, supported by its cost-effectiveness and widespread use in microbial identification and taxonomy studies.

Whole Genome Sequencing (WGS): Represent a growing segment, fueled by advancements in sequencing technologies and increasing demand for in-depth genomic insights.

Others: Include emerging sequencing approaches and hybrid technologies enhancing accuracy and efficiency.

➥ By Application

Clinical Diagnostics: Represent a rapidly growing segment, driven by increasing use in infectious disease detection and precision medicine.

Environmental Testing: Represent a significant segment, supported by applications in soil, water, and ecosystem monitoring.

Food & Agriculture: Represent a growing segment, fueled by need for food safety, quality control, and microbiome analysis in agriculture.

Drug Discovery & Development: Represent a dominant segment, driven by rising R&D investments and the role of metagenomics in identifying novel drug targets.

Others: Include biotechnology research, forensic analysis, and industrial microbiology expanding the scope of metagenomic sequencing.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.